GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Changchun BCHT Biotechnology Co (SHSE:688276) » Definitions » EV-to-EBITDA

Changchun BCHT Biotechnology Co (SHSE:688276) EV-to-EBITDA : 20.17 (As of Jun. 19, 2024)


View and export this data going back to 2021. Start your Free Trial

What is Changchun BCHT Biotechnology Co EV-to-EBITDA?

EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Changchun BCHT Biotechnology Co's enterprise value is ¥12,368 Mil. Changchun BCHT Biotechnology Co's EBITDA for the trailing twelve months (TTM) ended in Mar. 2024 was ¥613 Mil. Therefore, Changchun BCHT Biotechnology Co's EV-to-EBITDA for today is 20.17.

The historical rank and industry rank for Changchun BCHT Biotechnology Co's EV-to-EBITDA or its related term are showing as below:

SHSE:688276' s EV-to-EBITDA Range Over the Past 10 Years
Min: 19.95   Med: 84.75   Max: 156.33
Current: 20.17

During the past 7 years, the highest EV-to-EBITDA of Changchun BCHT Biotechnology Co was 156.33. The lowest was 19.95. And the median was 84.75.

SHSE:688276's EV-to-EBITDA is ranked worse than
67.98% of 709 companies
in the Drug Manufacturers industry
Industry Median: 14.49 vs SHSE:688276: 20.17

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-06-19), Changchun BCHT Biotechnology Co's stock price is ¥30.15. Changchun BCHT Biotechnology Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 was ¥1.320. Therefore, Changchun BCHT Biotechnology Co's PE Ratio for today is 22.84.

The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio.


Changchun BCHT Biotechnology Co EV-to-EBITDA Historical Data

The historical data trend for Changchun BCHT Biotechnology Co's EV-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Changchun BCHT Biotechnology Co EV-to-EBITDA Chart

Changchun BCHT Biotechnology Co Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-EBITDA
Get a 7-Day Free Trial - - 82.26 102.98 33.83

Changchun BCHT Biotechnology Co Quarterly Data
Dec18 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
EV-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 107.52 106.92 75.50 33.83 29.39

Competitive Comparison of Changchun BCHT Biotechnology Co's EV-to-EBITDA

For the Drug Manufacturers - Specialty & Generic subindustry, Changchun BCHT Biotechnology Co's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Changchun BCHT Biotechnology Co's EV-to-EBITDA Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Changchun BCHT Biotechnology Co's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Changchun BCHT Biotechnology Co's EV-to-EBITDA falls into.



Changchun BCHT Biotechnology Co EV-to-EBITDA Calculation

Changchun BCHT Biotechnology Co's EV-to-EBITDA for today is calculated as:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA (TTM)
=12368.077/613.138
=20.17

Changchun BCHT Biotechnology Co's current Enterprise Value is ¥12,368 Mil.
Changchun BCHT Biotechnology Co's EBITDA for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥613 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Changchun BCHT Biotechnology Co  (SHSE:688276) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

Changchun BCHT Biotechnology Co's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=30.15/1.320
=22.84

Changchun BCHT Biotechnology Co's share price for today is ¥30.15.
Changchun BCHT Biotechnology Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥1.320.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.

Please read Which price ratio outperforms the enterprise multiple?


Changchun BCHT Biotechnology Co EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Changchun BCHT Biotechnology Co's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


Changchun BCHT Biotechnology Co (SHSE:688276) Business Description

Traded in Other Exchanges
N/A
Address
No. 1260, Huoju Road, High-tech Development Zone, Jilin Province, Changchun, CHN, 130012
Changchun BCHT Biotechnology Co is a biopharmaceutical enterprise specializing in the research and development, production and sales of human vaccines.
Executives
Shi Nian Min Core technical personnel
Jiang Chun Lai Directors, senior managers, core technical personn
Zhu Chang Lin Core technical personnel
Wei Wei Senior management, core technical personnel
Yu Bing senior management
Liu Da Wei Senior management, core technical personnel
Meng Zhao Feng senior management
Zhang Zhe senior management
Kong Wei Directors, senior managers, core technical personn
Feng Da Qiang Supervisors

Changchun BCHT Biotechnology Co (SHSE:688276) Headlines

No Headlines